Zebrafish Liposarcoma Models

Introduction Model Details Phenotypic Evaluation Applications

Introduction

Liposarcoma is one of the most common soft tissue sarcomas in adults, originating from adipocytic lineage cells and accounting for approximately 15–20% of all soft tissue sarcomas. Based on histological and molecular characteristics, liposarcoma is classified into several subtypes, including well-differentiated liposarcoma (WDLPS), dedifferentiated liposarcoma (DDLPS), myxoid liposarcoma (MLPS), and pleomorphic liposarcoma (PLPS). Clinical presentation varies depending on tumor location and subtype, with deep soft tissues of the extremities and retroperitoneum being the most frequent sites. High-grade subtypes are associated with local recurrence, metastatic progression, and unfavorable prognosis.

Complete surgical resection remains the primary treatment for localized disease, while radiotherapy and conventional chemotherapy are used in selected patients. Recent studies have explored targeted therapies directed against molecular alterations such as MDM2 and CDK4 amplification or fusion-driven signaling pathways in myxoid liposarcoma. However, treatment options for advanced or recurrent disease remain limited due to tumor heterogeneity, subtype-specific biology, therapeutic resistance, and the lack of predictive in vivo models. Robust animal models are therefore essential for investigating disease mechanisms and evaluating novel therapeutic strategies.

Why Zebrafish?

Rapid engraftment: Human liposarcoma cells readily engraft in zebrafish larvae.
Real-time visualization: Transparent embryos enable visualization of tumor growth and dissemination.
Efficacy evaluation: Suitable for evaluating anti-tumor efficacy in vivo.
Phenotypic screening: Supports rapid phenotypic drug screening.

Available Zebrafish Disease Models

Validated zebrafish liposarcoma models are predominantly based on xenotransplantation of established human cell lines or patient-derived tumor samples. These models are widely used for evaluating tumor progression, invasion, and therapeutic response.

Model Name	Induction Method	Features
Human Liposarcoma Cell Xenograft Model	Fluorescently labeled human liposarcoma cell lines (e.g., SW872, 93T449, LPS141) are microinjected into the yolk sac or perivitelline space of 48–72 hpf zebrafish embryos.	The most commonly used model for assessing tumor growth, invasion, angiogenesis, and anti-tumor drug efficacy.
Patient-Derived Liposarcoma Xenograft (zPDX) Model	Fresh patient-derived liposarcoma cells or tumor fragments are fluorescently labeled and transplanted into 2 dpf zebrafish larvae.	Preserves patient-specific molecular and histopathological characteristics for personalized drug sensitivity studies.
Metastatic Liposarcoma Xenograft Model	Highly invasive liposarcoma cells are injected into the duct of Cuvier or circulation to evaluate tumor dissemination and metastatic behavior.	Suitable for investigating metastatic mechanisms and evaluating anti-metastatic therapies.

Note: Unlike Ewing sarcoma, no well-established genetically engineered zebrafish model has yet been reported for liposarcoma. Current zebrafish studies primarily employ xenograft-based models.

Phenotypic Evaluation

Tumor Growth

Tumor size
Tumor burden
Cell proliferation

Tumor Invasion

Local invasion
Tumor cell dissemination
Migration distance

Tumor Angiogenesis

Neovascularization
Vessel density
Tumor–vessel interaction

Therapeutic Response

Tumor growth inhibition
Apoptosis induction
Drug sensitivity

Key Applications

MDM2/CDK4-Targeted Therapy Evaluation: Assess candidate therapeutics targeting the amplified MDM2–CDK4 signaling axis in well-differentiated and dedifferentiated liposarcoma.
Myxoid Liposarcoma Biology: Investigate molecular pathways associated with fusion-driven myxoid liposarcoma and tumor progression.
Tumor Invasion and Local Recurrence Studies: Evaluate mechanisms regulating local invasion and recurrence following therapeutic intervention.
Drug Resistance Research: Study resistance to chemotherapy and targeted agents in advanced liposarcoma.
Personalized Drug Sensitivity Testing: Evaluate individualized therapeutic responses using patient-derived zebrafish xenograft models.

Accelerate Liposarcoma Research with Zebrafish Models

Our zebrafish liposarcoma models provide reliable in vivo platforms for investigating tumor growth, invasion, angiogenesis, and therapeutic response. We offer customized xenograft establishment, phenotypic analysis, and preclinical drug efficacy studies to support translational research and anti-sarcoma drug development.

Contact Our Scientists

For research use only. Not intended for any clinical use.